文献速递糖尿病

主动脉僵硬度与动态血压预测糖尿病肾病:里约热内卢2型糖尿病队列研究的竞争风险分析

Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study.
PubMed 文献 · Diabetologia · 2017-10-23

该前瞻性队列纳入629例无晚期肾衰竭的2型糖尿病高危个体,中位随访7.8年,采用竞争风险分析(Fine和Gray法)评估动态血压和主动脉僵硬度对糖尿病肾病发生或进展的预测作用。结果发现血糖和血压控制不佳及主动脉僵硬度增加是糖尿病肾病发生或进展的主要预测因素,动态收缩压预测优于诊室血压。

要点

  • 动态收缩压和主动脉僵硬度是糖尿病肾病发生或进展的独立预测因素。
  • 主动脉僵硬度预测异常白蛋白尿发生或进展,动态血压预测肾功能恶化更强。
  • 作者认为动态血压监测和主动脉僵硬度评估应更广泛用于2型糖尿病临床管理。

核心结论

  • 血糖和血压控制不佳及主动脉僵硬度增加是糖尿病肾病发生或进展的主要预测因素,动态收缩压预测优于诊室血压。

研究设计与样本

  • 前瞻性研究纳入629例无晚期肾衰竭的2型糖尿病个体,每年评估肾功能,中位随访7.8年。
  • 基线时监测动态血压,并通过颈-股脉搏波速度评估主动脉僵硬度。
  • 采用Fine和Gray法进行多因素竞争风险分析,以全因死亡为竞争事件。

主要发现

  • 基线时197例个体患有糖尿病肾病;随访期间195例发生或进展糖尿病肾病,125例异常白蛋白尿发生或进展,91例肾功能恶化。
  • 调整基线白蛋白尿和肾功能、年龄、性别、糖尿病病程及肾素-血管紧张素拮抗剂使用后,第一年平均HbA1c每增加1个标准差,糖尿病肾病发生或进展的HR为1.17(95% CI 0.98,1.40;p=0.09)。
  • 日间收缩压每增加1个标准差,糖尿病肾病发生或进展的HR为1.28(95% CI 1.09,1.50;p=0.003);主动脉僵硬度增加的HR为1.16(95% CI 1.00,1.34;p=0.05)。
  • 基线时动态血压比诊室血压是更强的预测因素;主动脉僵硬度预测异常白蛋白尿发生或进展的HR为1.26(95% CI 1.02,1.56;p=0.036);日间收缩压预测肾功能恶化的HR为1.32(95% CI 1.09,1.60;p=0.005)。

临床怎么用

  • 作者认为动态血压监测和主动脉僵硬度评估应更广泛用于2型糖尿病临床管理。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: Diabetic kidney disease (DKD) is a microvascular complication associated with poor control of blood glucose and BP. We aimed to evaluate the predictors of development and progression of DKD in a cohort of high-risk individuals with type 2 diabetes, placing emphasis on ambulatory BP and arterial stiffness. METHODS: In a prospective study, 629 individuals without advanced renal failure had their renal function evaluated annually over a median follow-up period of 7.8 years. Ambulatory BP was monitored and aortic stiffness was assessed by carotid-femoral pulse wave velocity at baseline. Multivariate competing risks analysis with all-cause mortality, using the Fine and Gray approach, was used to examine the independent predictors of development and progression of DKD, a composite of development or progression of abnormal albuminuria and worsening of renal function (doubling of serum creatinine or progression to end-stage renal disease). RESULTS: At baseline, 197 individuals had DKD. During follow-up, DKD developed or progressed in 195 individuals, abnormal albuminuria developed or progressed in 125 individuals and renal function deteriorated in 91. After adjustments for baseline albuminuria and renal function, age, sex, diabetes duration and use of renin-angiotensin antagonists, poorer control of blood glucose (HR 1.17; 95% CI 0.98, 1.40; p = 0.09 for each 1 SD increment in mean first-year HbA1c), higher ambulatory systolic BP (HR 1.28; 95% CI 1.09, 1.50; p = 0.003, for each 1 SD increase in daytime systolic BP [SBP]) and increased aortic stiffness (HR 1.16; 95% CI 1.00, 1.34; p = 0.05) were independent predictors of development or progression of DKD. At baseline, ambulatory BP was a stronger predictor than BP measured in the clinic. Aortic stiffness predicted abnormal albuminuria development or progression (HR 1.26; 95% CI 1.02, 1.56; p = 0.036) whereas ambulatory BP was a stronger predictor of renal function deterioration (HR 1.32; 95% CI 1.09, 1.60; p = 0.005 for daytime SBP). CONCLUSIONS/INTERPRETATION: Poor blood glucose and BP control and increased aortic stiffness were the main predictors of development or progression of DKD; ambulatory SBP was a better predictor than BP measured in the clinic. Ambulatory BP monitoring and assessment of aortic stiffness should be more widely used in clinical type 2 diabetes management.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Cardoso CRL, Leite NC, Salles GC, et al. Aortic stiffness and ambulatory blood pressure as predictors of diabetic kidney disease: a competing risks analysis from the Rio de Janeiro Type 2 Diabetes Cohort Study. Diabetologia. 2017. PMID: 29063128. doi:10.1007/s00125-017-4484-z

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。